Prolog Ventures

CoverCress Inc. specializes in developing and commercializing field pennycress as a sustainable oilseed crop for industrial oils and livestock feed. Founded in 2013, the company is headquartered in Saint Louis, Missouri.

CoverCress Inc. specializes in developing and commercializing field pennycress as a sustainable oilseed crop for industrial oils and livestock feed. Founded in 2013, the company is headquartered in Saint Louis, Missouri.

CoverCress Inc. specializes in developing and commercializing field pennycress as a sustainable oilseed crop for industrial oils and livestock feed. Founded in 2013, the company is headquartered in Saint Louis, Missouri.

Veran Medical Technologies is an image-guided medical device company that develops minimally invasive tools for interventional oncology and pulmonology. Its products enable physicians to diagnose cancer earlier and deliver targeted therapies through navigation and real-time visualization. The portfolio includes SPiNView thoracic navigation system, SPiNPerc, SPiN Drive System, vPad2, and vTrack 2.0 instruments to guide biopsies and other procedures in the lungs, as well as ig4 IR System, an electromagnetic navigation platform that supports biopsies, drainages, and ablations in the lungs, liver, and kidneys. The IG4 Platform integrates CT data with respiration, contrast-enhanced structures, PET, and ultrasound to provide a dynamic, three-dimensional airway roadmap during procedures. Veran is based in St. Louis, Missouri.

Founded in 2007, Neurolutions develops non-invasive brain-computer interface devices aimed at restoring functionality to individuals disabled by neurological injuries. Their technology uses electroencephalography (EEG) electrodes to interpret intended muscle movements, facilitating rehabilitation and maintaining range of motion.

CoverCress Inc. specializes in developing and commercializing field pennycress as a sustainable oilseed crop for industrial oils and livestock feed. Founded in 2013, the company is headquartered in Saint Louis, Missouri.

Veran Medical Technologies is an image-guided medical device company that develops minimally invasive tools for interventional oncology and pulmonology. Its products enable physicians to diagnose cancer earlier and deliver targeted therapies through navigation and real-time visualization. The portfolio includes SPiNView thoracic navigation system, SPiNPerc, SPiN Drive System, vPad2, and vTrack 2.0 instruments to guide biopsies and other procedures in the lungs, as well as ig4 IR System, an electromagnetic navigation platform that supports biopsies, drainages, and ablations in the lungs, liver, and kidneys. The IG4 Platform integrates CT data with respiration, contrast-enhanced structures, PET, and ultrasound to provide a dynamic, three-dimensional airway roadmap during procedures. Veran is based in St. Louis, Missouri.

Veran Medical Technologies is an image-guided medical device company that develops minimally invasive tools for interventional oncology and pulmonology. Its products enable physicians to diagnose cancer earlier and deliver targeted therapies through navigation and real-time visualization. The portfolio includes SPiNView thoracic navigation system, SPiNPerc, SPiN Drive System, vPad2, and vTrack 2.0 instruments to guide biopsies and other procedures in the lungs, as well as ig4 IR System, an electromagnetic navigation platform that supports biopsies, drainages, and ablations in the lungs, liver, and kidneys. The IG4 Platform integrates CT data with respiration, contrast-enhanced structures, PET, and ultrasound to provide a dynamic, three-dimensional airway roadmap during procedures. Veran is based in St. Louis, Missouri.

Akermin, Inc. is a biocatalyst development company based in St. Louis, Missouri, founded in 2003. The company specializes in innovative solutions for the removal of carbon dioxide (CO2) from industrial gas streams, utilizing biocatalysis and nanotechnology. Akermin has developed proprietary delivery systems that enable the integration of enzymes into traditional chemical absorption processes for effective CO2 removal. In addition to its primary focus on carbon capture, Akermin is also exploring applications of its stabilized enzyme technology in various sectors, including food processing, biofuels, chemicals, and pharmaceuticals. The company aims to commercialize its technology, which originated from research at Saint Louis University, and has demonstrated its capabilities in developing sustainable solutions for a range of industries.

Veran Medical Technologies is an image-guided medical device company that develops minimally invasive tools for interventional oncology and pulmonology. Its products enable physicians to diagnose cancer earlier and deliver targeted therapies through navigation and real-time visualization. The portfolio includes SPiNView thoracic navigation system, SPiNPerc, SPiN Drive System, vPad2, and vTrack 2.0 instruments to guide biopsies and other procedures in the lungs, as well as ig4 IR System, an electromagnetic navigation platform that supports biopsies, drainages, and ablations in the lungs, liver, and kidneys. The IG4 Platform integrates CT data with respiration, contrast-enhanced structures, PET, and ultrasound to provide a dynamic, three-dimensional airway roadmap during procedures. Veran is based in St. Louis, Missouri.

Akermin, Inc. is a biocatalyst development company based in St. Louis, Missouri, founded in 2003. The company specializes in innovative solutions for the removal of carbon dioxide (CO2) from industrial gas streams, utilizing biocatalysis and nanotechnology. Akermin has developed proprietary delivery systems that enable the integration of enzymes into traditional chemical absorption processes for effective CO2 removal. In addition to its primary focus on carbon capture, Akermin is also exploring applications of its stabilized enzyme technology in various sectors, including food processing, biofuels, chemicals, and pharmaceuticals. The company aims to commercialize its technology, which originated from research at Saint Louis University, and has demonstrated its capabilities in developing sustainable solutions for a range of industries.

Veran Medical Technologies is an image-guided medical device company that develops minimally invasive tools for interventional oncology and pulmonology. Its products enable physicians to diagnose cancer earlier and deliver targeted therapies through navigation and real-time visualization. The portfolio includes SPiNView thoracic navigation system, SPiNPerc, SPiN Drive System, vPad2, and vTrack 2.0 instruments to guide biopsies and other procedures in the lungs, as well as ig4 IR System, an electromagnetic navigation platform that supports biopsies, drainages, and ablations in the lungs, liver, and kidneys. The IG4 Platform integrates CT data with respiration, contrast-enhanced structures, PET, and ultrasound to provide a dynamic, three-dimensional airway roadmap during procedures. Veran is based in St. Louis, Missouri.

Akermin, Inc. is a biocatalyst development company based in St. Louis, Missouri, founded in 2003. The company specializes in innovative solutions for the removal of carbon dioxide (CO2) from industrial gas streams, utilizing biocatalysis and nanotechnology. Akermin has developed proprietary delivery systems that enable the integration of enzymes into traditional chemical absorption processes for effective CO2 removal. In addition to its primary focus on carbon capture, Akermin is also exploring applications of its stabilized enzyme technology in various sectors, including food processing, biofuels, chemicals, and pharmaceuticals. The company aims to commercialize its technology, which originated from research at Saint Louis University, and has demonstrated its capabilities in developing sustainable solutions for a range of industries.

Chlorogen a biopharmaceutical company, engages in the development and manufacture of proteins for human therapy. The company, through its chloroplast transformation technology (CTT), offers plant made drugs for the treatment and prevention of human diseases, as well as for treatment of women's reproductive cancers. Its products include therapeutic proteins in tobacco that are made using chloroplast transformation technology. The chloroplast transformation technology facilitates hyper-expression of recombinant proteins in tobacco chloroplasts. The company offers its chloroplast-tobacco platform for commercial use in food and agriculture. Chlorogen, Inc. was founded in 2002 and is based in St. Louis, Missouri.

Akermin, Inc. is a biocatalyst development company based in St. Louis, Missouri, founded in 2003. The company specializes in innovative solutions for the removal of carbon dioxide (CO2) from industrial gas streams, utilizing biocatalysis and nanotechnology. Akermin has developed proprietary delivery systems that enable the integration of enzymes into traditional chemical absorption processes for effective CO2 removal. In addition to its primary focus on carbon capture, Akermin is also exploring applications of its stabilized enzyme technology in various sectors, including food processing, biofuels, chemicals, and pharmaceuticals. The company aims to commercialize its technology, which originated from research at Saint Louis University, and has demonstrated its capabilities in developing sustainable solutions for a range of industries.

Kereos, Inc. is a biopharmaceutical company based in St. Louis, Missouri, specializing in the development of nanoscale drug delivery technologies and molecular imaging agents aimed at the detection and treatment of cancer and cardiovascular diseases. Founded in 1999, Kereos focuses on targeted delivery systems that enhance the effectiveness of therapeutic compounds, including existing drugs and novel candidates, particularly those that are too toxic or fragile for conventional delivery methods. The company's product portfolio includes KER-1001 and KER-1002, both cancer therapeutics utilizing natural products with demonstrated anti-tumor efficacy, and KER-1003, which targets angiogenesis. Additionally, Kereos offers diagnostic applications, such as KER 0001, an imaging platform for detecting angiogenesis. The company is also engaged in developing partnerships with pharmaceutical and imaging firms to advance its molecular imaging systems and cardiovascular disease MRI agents, thereby broadening its impact in the healthcare sector.

Chlorogen a biopharmaceutical company, engages in the development and manufacture of proteins for human therapy. The company, through its chloroplast transformation technology (CTT), offers plant made drugs for the treatment and prevention of human diseases, as well as for treatment of women's reproductive cancers. Its products include therapeutic proteins in tobacco that are made using chloroplast transformation technology. The chloroplast transformation technology facilitates hyper-expression of recombinant proteins in tobacco chloroplasts. The company offers its chloroplast-tobacco platform for commercial use in food and agriculture. Chlorogen, Inc. was founded in 2002 and is based in St. Louis, Missouri.

Quick Study Radiology provides digital imaging solutions for community hospitals, radiology and oncology practices, and imaging centers. The company offers image and data archiving, and disaster recovery services; monitoring and security services; and networking and web distribution services. It also provides picture archiving and communication systems for community hospitals and other facilities, and radiology information systems to store, manage, and distribute patient’s data and imagery. Quick Study Radiology was founded in 1999 and is based in Saint Louis, Missouri.

Quick Study Radiology provides digital imaging solutions for community hospitals, radiology and oncology practices, and imaging centers. The company offers image and data archiving, and disaster recovery services; monitoring and security services; and networking and web distribution services. It also provides picture archiving and communication systems for community hospitals and other facilities, and radiology information systems to store, manage, and distribute patient’s data and imagery. Quick Study Radiology was founded in 1999 and is based in Saint Louis, Missouri.

Chlorogen a biopharmaceutical company, engages in the development and manufacture of proteins for human therapy. The company, through its chloroplast transformation technology (CTT), offers plant made drugs for the treatment and prevention of human diseases, as well as for treatment of women's reproductive cancers. Its products include therapeutic proteins in tobacco that are made using chloroplast transformation technology. The chloroplast transformation technology facilitates hyper-expression of recombinant proteins in tobacco chloroplasts. The company offers its chloroplast-tobacco platform for commercial use in food and agriculture. Chlorogen, Inc. was founded in 2002 and is based in St. Louis, Missouri.